Xue Yang

Chengdu, 610000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Exploration of the Interaction Between Bismuth-Containing Quadruple Anti-H. pylori Therapy and the Gut Microbiota.

Exploration of the Interaction Between Bismuth-Containing Quadruple Anti-H. pylori Therapy and the Gut Microbiota.

Journal: Microorganisms

Published: June 09, 2026

Β-Resorcylaldehyde attenuates DSS-induced colitis by inhibiting inflammation and oxidative stress through the Keap1/Nrf2/HO-1 pathway.

Β-Resorcylaldehyde attenuates DSS-induced colitis by inhibiting inflammation and oxidative stress through the Keap1/Nrf2/HO-1 pathway.

Journal: International immunopharmacology

Published: April 06, 2026

The Effect of Drugs on the Intestinal Microbiota in Crohn's Disease.

The Effect of Drugs on the Intestinal Microbiota in Crohn's Disease.

Journal: Biomedicines

Published: August 25, 2024

Banxia Xiexin Tang attenuates high glucose-induced hepatocyte injury by activating SOD2 to scavenge ROS via PGC-1α/IGFBP1.

Banxia Xiexin Tang attenuates high glucose-induced hepatocyte injury by activating SOD2 to scavenge ROS via PGC-1α/IGFBP1.

Journal: 3 Biotech

Published: July 09, 2024

Prominence of Microbiota to Predict Fibrous Stenosis in Crohn's Disease.

Prominence of Microbiota to Predict Fibrous Stenosis in Crohn's Disease.

Journal: Journal of inflammation research

Published: May 29, 2024

Association between serum omentin-1 and mucosal disease activity in patients with ulcerative colitis.

Association between serum omentin-1 and mucosal disease activity in patients with ulcerative colitis.

Journal: Postgraduate medical journal

Published: June 15, 2023

Clinical significance of a novel uric-acid-based biomarker in the prediction of disease activity and response to infliximab therapy in Crohn's disease.

Clinical significance of a novel uric-acid-based biomarker in the prediction of disease activity and response to infliximab therapy in Crohn's disease.

Journal: Scandinavian journal of gastroenterology

Published: February 25, 2023

A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis.

A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis.

Journal: Frontiers in medicine

Published: February 10, 2022

Clinical Significance of Novel Neutrophil-Based Biomarkers in the Diagnosis and Prediction of Response to Infliximab Therapy in Crohn's Disease.

Clinical Significance of Novel Neutrophil-Based Biomarkers in the Diagnosis and Prediction of Response to Infliximab Therapy in Crohn's Disease.

Journal: Frontiers in immunology

Published: January 30, 2022

Ascl2 facilitates IL-10 production in Th17 cells to restrain their pathogenicity in inflammatory bowel disease.

Ascl2 facilitates IL-10 production in Th17 cells to restrain their pathogenicity in inflammatory bowel disease.

Journal: Biochemical and biophysical research communications

Published: January 05, 2019

New advances in microfluidic flow cytometry.

New advances in microfluidic flow cytometry.

Journal: Electrophoresis

Published: July 15, 2018

Numerical and experimental investigation of 'water fan' effect due to electrohydrodynamic force in a microchamber.

Numerical and experimental investigation of 'water fan' effect due to electrohydrodynamic force in a microchamber.

Journal: Electrophoresis

Published: June 30, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026